Loading clinical trials...
Loading clinical trials...
Reducing Racial Disparities in Cancer Care With PINPOINT (Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy)
The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).
The website offers tools for discussing innovative treatments with their clinicians, finding clinical trials, and locating support groups. We are conducting key informant interviews, testing the website with pilot tester and asking volunteers from our Community Advisory Board to review our website prototype to further improve its design and features.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
The Rutgers Cancer Institute
New Brunswick, New Jersey, United States
Start Date
July 12, 2021
Primary Completion Date
May 19, 2023
Completion Date
May 19, 2023
Last Updated
August 11, 2025
81
ACTUAL participants
PINPOINT Digital Educational Tool
BEHAVIORAL
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
NCT05689463
NCT06488950
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05098197